Lysyl Oxidase (LOX) Family Proteins: Key Players in Breast Cancer Occurrence and Progression
Journal of Cancer · 2024 · 15 (16) · 5230-5243
DOI: 10.7150/jca.98688 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer, 2024. Verfasst von Jinsong Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali 671000, Yunnan, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dali University, Dali 671000, Yunnan, China.
- Key Laboratory of Clinical Biochemistry Testing in Universities of Yunnan Province, College of Basic Medical Sciences, Dali University, Dali 671000, Yunnan, China.
- Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali 671000, Yunnan, China.
- Department of Radiology, The First Affiliated Hospital of Dali University, Dali University, Dali 671000, Yunnan, China.
Zitieren
APA
Li, J., Wang, X., Liu, R., Zi, J., Li, Y., Li, Z., & Xiong, W. (2024). Lysyl Oxidase (LOX) Family Proteins: Key Players in Breast Cancer Occurrence and Progression. Journal of Cancer, 15(16), 5230-5243. https://doi.org/10.7150/jca.98688
Vancouver
Li J, Wang X, Liu R, Zi J, Li Y, Li Z, et al. Lysyl Oxidase (LOX) Family Proteins: Key Players in Breast Cancer Occurrence and Progression. Journal of Cancer. 2024;15(16):5230-5243. doi:10.7150/jca.98688
BibTeX
@article{Li2024,
author = {Li, Jinsong and Wang, Xinmeng and Liu, Ruai and Zi, Jiaji and Li, Yihan and Li, Zhengliang and Xiong, Wei},
title = {Lysyl Oxidase (LOX) Family Proteins: Key Players in Breast Cancer Occurrence and Progression},
journal = {Journal of Cancer},
year = {2024},
volume = {15},
number = {16},
pages = {5230--5243},
doi = {10.7150/jca.98688}
}
EUVIMED